March 28, 2012
/PRNewswire/ -- Every day, 5.6 million healthcare personnel in the U.S. are put at risk of occupational exposure to HIV, hepatitis C and other life-threatening blood-borne diseases via transmission modes such as needlestick injuries.
Safe in Common, a non-profit organization of healthcare safety advocates, is launching a nationwide campaign to unite 100,000 U.S. healthcare personnel who believe current Federal standards for needlestick prevention are largely inadequate and that safer devices and other measures are needed to maximize protection to those at risk of harm.
The Needlestick Safety Advocacy Tour being led by Safe in Common will visit more than 50 U.S. hospitals and attend more than a dozen healthcare conferences across 36 metropolitan centers during the coming 12 months.
, Chairperson of Safe in Common, stated: "As President of the American Nursing Association during the adoption of the Federal Needlestick Prevention Act in 2000, I was honored to have helped our industry take a vital first step toward protecting healthcare personnel at risk of injury. But we must now come together again to help finish the job. I firmly believe that every needlestick injury is preventable with the right equipment, the right procedures and the right culture. I encourage all U.S. healthcare personnel to join me in the signing of the Safe in Common Pledge."
, Healthcare Safety Advocate for Safe in Common stated: "The risk of contracting a blood-borne disease from a needlestick injury was one of my greatest fears during my 25 year career in nursing. Millions of healthcare personnel continue to share my concern today. It is unacceptable that so many of my colleagues remain at significant risk of sustaining a needlestick injury, despite government enforcement of Federal standards mandating the use of safety engineered medical equipment and other measures within healthcare facilities. Safe in Common looks forward to engaging with healthcare personnel across the U.S. to listen to their injection safety concerns and raise industry awareness about ways in which we can work together to move beyond compliance and deliver true protection for all those at risk of needlestick injuries."
To receive more information about the Needlestick Safety Advocacy Tour, or to take the pledge, please visit
Unilife Corporation, a U.S.-based developer and manufacturer of advanced drug delivery systems, has proudly agreed to sponsor Safe in Common and the Needlestick Safety Advocacy Tour.